# Characterization of Removal Capacities of the Theranova Membrane by Proteomic Investigations

> **NCT03137056** · NA · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 20 (estimated)

## Conditions studied

- Dialysis Membrane Reaction

## Interventions

- **DEVICE:** Hemodialysis with Theranova
- **DEVICE:** Hemodialysis with FX1000
- **DEVICE:** Hemodiafiltration with FX1000

## Key facts

- **NCT ID:** NCT03137056
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03137056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03137056, "Characterization of Removal Capacities of the Theranova Membrane by Proteomic Investigations". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03137056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*